Bruker Reports Third Quarter 2026 Financial Results
Bruker Corporation announced its financial results for the third quarter and nine months ended September 30, 2026.
Stocks · News reference
Barclays Maintains Overweight on Bruker, Raises Price Target to $70
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.
JP Morgan Downgrades Bruker to Neutral, Announces $60 Price Target
JP Morgan analyst Casey Woodring downgrades Bruker (NASDAQ:BRKR) from Overweight to Neutral and announces $60 price target.
TD Cowen Maintains Hold on Bruker, Raises Price Target to $62
TD Cowen analyst Kyle Boucher maintains Bruker (NASDAQ:BRKR) with a Hold and raises the price target from $60 to $62.
Guggenheim Maintains Buy on Bruker, Raises Price Target to $72
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $80